title: [Where does the development of new antituberculotics go? Part 2 - in vitro evaluation].
abstract: The present paper is a continuation of a publication of 2012 (Čes. a slov. Farm. 2012; 31, 150-158). It is oriented at the evaluation of potential antituberculotics in vitro, which is the most widely used approach to testing. The paper is based on the information from Chemical Abstracts 2011-2013. It is a selection from nearly three thousand items of information intended to help researchers. The greatest attention is paid to the multiresistant strains of Mycobacterium tuberculosis. In vitro evaluation for the development of new drugs is of great importance, but it is just the first stretch of the road to new medicinal drugs.
authors.forename: Karel
authors.initials: K
authors.lastname: Waisser
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D015195:Drug Design; D006801:Humans; D066298:In Vitro Techniques; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents